President Donald Trump announced on Thursday (September 25, 2025) a 100% tariff on branded and patented pharmaceutical imports , effective October 1, 2025, unless companies establish manufacturing facilities in the United States. While generic medicines — India’s main export to America — are excluded on paper, the move has the potential to unsettle the $20 billion industry that supplies nearly 40 per cent of US generics.

“Starting October 1, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America,” Mr. Trump declared on his social media platform.

He said “IS BUILDING” would mean “breaking ground” or “under construction,” adding that products from firms already investing i

See Full Page